Peptable

Comparison

Kisspeptin vs TB-500

Function

While Kisspeptin is a key regulator of the hypothalamic–pituitary–gonadal axis, controlling puberty and fertility; kisspeptin-10 also inhibits trophoblast invasion and tumor metastasis in experimental models339199, TB-500 is studied for enhancing musculoskeletal and cardiac repair, wound healing, and promoting cell migration and differentiation via actin cytoskeleton remodeling21255.

Mechanism

While Kisspeptin works as a family of peptides (eg, kisspeptin-10, -13, -14, -54) derived from the KISS1 precursor that activate G-protein–coupled receptor KISS1R (GPR54), triggering GnRH release and regulating pubertal onset and reproductive axis activity339199, TB-500 is a synthetic peptide comprising the LKKTETQ actin-binding motif of thymosin beta-4 that binds G-actin, sequesters actin monomers, and promotes cell migration, angiogenesis, and tissue repair1255.

Receptor

Kisspeptin

KISS1R (GPR54) kisspeptin receptor33919943

TB-500

Binds monomeric actin (G-actin) rather than a classical cell-surface receptor, modulating actin polymerization at barbed and pointed ends55

Organism or Origin

Kisspeptin

Endogenous human peptide products of the KISS1 gene9199

TB-500

Synthetic derivative of human thymosin beta-4, whose full-length 43-amino-acid protein is abundant in mammalian tissues21279

Gene

Kisspeptin

KISS1

TB-500

TMSB4X

Summary

Kisspeptin and TB-500 are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: Kisspeptin is more often discussed in the realm of Reproductive health, whereas TB-500 is more often associated with the realm of Musculoskeletal health and Cardiovascular health. Their biological logic is quite different: Kisspeptin is a receptor agonist, whereas TB-500 is a signaling modulator and a growth factor mimetic. Kisspeptin has a more natural endogenous origin, while TB-500 is closer to synthetic analog background and both are still best understood as being in Preclinical development. Kisspeptin incorporates amidation features that are not part of TB-500, while their sequence patterns also diverge, with Kisspeptin showing alpha-helical domain features and TB-500 showing protein-mimetic sequence features.

Sources

70Kisspeptin-10, rat, https://pubchem.ncbi.nlm.nih.gov/compound/Kisspeptin-10_-rat
91Kisspeptin - Wikipedia, https://en.wikipedia.org/wiki/Kisspeptin
99Kisspeptin-1 - an overview, https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/kisspeptin-1
2TB-500 (Thymosin Beta-4) | Peptide Biologix, https://peptidebiologix.com/tb-500
12Thymosin Beta-4 vs TB-500 | What to Know in 2024, https://www.peptidesciences.com/peptide-research/thymosin-beta-4-vs-tb-500
79TMSB4X Gene: Function, Research, and Clinical Applications, https://learn.mapmygenome.in/genemap/tmsb4x